These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7015846

  • 41. Effect of simethicone on lactulose-induced H2 production and gastrointestinal symptoms.
    Friis H, Bodé S, Rumessen JJ, Gudmand-Høyer E.
    Digestion; 1991; 49(4):227-30. PubMed ID: 1797602
    [Abstract] [Full Text] [Related]

  • 42. Impaired intestinal gas clearance during marked hyperglycemia in patients with functional abdominal bloating.
    Hernando-Harder AC, Riddinger F, Krammer HJ, Brade J, Singer MV, Harder H.
    Digestion; 2006; 74(3-4):155-61. PubMed ID: 17341848
    [Abstract] [Full Text] [Related]

  • 43. [Dimethicone in lactulose-induced dyspepsia. Effect on H2 production and symptoms].
    Friis H, Bodé SH, Rumessen JJ, Gudmand-Høyer E.
    Ugeskr Laeger; 1993 Oct 18; 155(42):3378-80. PubMed ID: 8259628
    [Abstract] [Full Text] [Related]

  • 44. Nutrient modulation of intestinal gas dynamics in healthy humans: dependence on caloric content and meal consistency.
    Gonlachanvit S, Coleski R, Owyang C, Hasler WL.
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep 18; 291(3):G389-95. PubMed ID: 16899712
    [Abstract] [Full Text] [Related]

  • 45. Fructose intake at current levels in the United States may cause gastrointestinal distress in normal adults.
    Beyer PL, Caviar EM, McCallum RW.
    J Am Diet Assoc; 2005 Oct 18; 105(10):1559-66. PubMed ID: 16183355
    [Abstract] [Full Text] [Related]

  • 46. Evaluation of an extremely flatulent patient: case report and proposed diagnostic and therapeutic approach.
    Levitt MD, Furne J, Aeolus MR, Suarez FL.
    Am J Gastroenterol; 1998 Nov 18; 93(11):2276-81. PubMed ID: 9820415
    [Abstract] [Full Text] [Related]

  • 47. Etiology and management of intestinal gas.
    Weiss J.
    Curr Ther Res Clin Exp; 1974 Sep 18; 16(9):909-20. PubMed ID: 4214666
    [No Abstract] [Full Text] [Related]

  • 48. Effect of activated charcoal administration on acetylcysteine serum levels in humans.
    North DS, Peterson RG, Krenzelok EP.
    Am J Hosp Pharm; 1981 Jul 18; 38(7):1022-4. PubMed ID: 7258201
    [Abstract] [Full Text] [Related]

  • 49. How much lactose is low lactose?
    Hertzler SR, Huynh BC, Savaiano DA.
    J Am Diet Assoc; 1996 Mar 18; 96(3):243-6. PubMed ID: 8613657
    [Abstract] [Full Text] [Related]

  • 50. Alpha-galactosidase to prevent gas.
    Med Lett Drugs Ther; 1993 Apr 02; 35(893):29-30. PubMed ID: 8383798
    [No Abstract] [Full Text] [Related]

  • 51. Effect of five percent dehydration on breath hydrogen concentrations in dogs.
    Bissett SA, Guilford WG, Haslett SJ, Sunvold GD.
    Am J Vet Res; 1998 Mar 02; 59(3):245-9. PubMed ID: 9522937
    [Abstract] [Full Text] [Related]

  • 52. Delta 10 ppm versus delta 20 ppm: a reappraisal of diagnostic criteria for breath hydrogen testing in children.
    Veligati LN, Treem WR, Sullivan B, Burke G, Hyams JS.
    Am J Gastroenterol; 1994 May 02; 89(5):758-61. PubMed ID: 8172152
    [Abstract] [Full Text] [Related]

  • 53. Intestinal gas formation and the use of breath measurements to monitor the influence of diet and disease.
    Brydon WG, McKay LF, Eastwood MA.
    Dig Dis; 1986 May 02; 4(1):1-12. PubMed ID: 3545558
    [Abstract] [Full Text] [Related]

  • 54. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC, Christophersen AB, Christensen HR, Angelo HR.
    Clin Toxicol (Phila); 2005 May 02; 43(4):269-75. PubMed ID: 16035203
    [Abstract] [Full Text] [Related]

  • 55. The frequency of complications associated with the use of multiple-dose activated charcoal.
    Dorrington CL, Johnson DW, Brant R, Multiple Dose Activated Charcoal Complication Study Group.
    Ann Emerg Med; 2003 Mar 02; 41(3):370-7. PubMed ID: 12605204
    [Abstract] [Full Text] [Related]

  • 56. Gaseousness and intestinal gas.
    Bond JH, Levitt MD.
    Med Clin North Am; 1978 Jan 02; 62(1):155-64. PubMed ID: 340816
    [No Abstract] [Full Text] [Related]

  • 57. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 2001 Sep 02; 70(3):255-60. PubMed ID: 11557913
    [Abstract] [Full Text] [Related]

  • 58. Flatulence: pathophysiology and treatment.
    Van Ness MM, Cattau EL.
    Am Fam Physician; 1985 Apr 02; 31(4):198-208. PubMed ID: 3984823
    [No Abstract] [Full Text] [Related]

  • 59. Enterohepatic recirculation of oestriol: inhibition by activated charcoal.
    Heimer GM, Englund DE.
    Acta Endocrinol (Copenh); 1986 Sep 02; 113(1):93-5. PubMed ID: 3766051
    [Abstract] [Full Text] [Related]

  • 60. [Enterosorption as a method of detoxification (review of the literature)].
    Mamyrbaev AM, Takhtaev FKh.
    Gig Tr Prof Zabol; 1990 Sep 02; (3):40-3. PubMed ID: 2351289
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.